Literature DB >> 8627696

Entry kinetics and mouse virulence of Ross River virus mutants altered in neutralization epitopes.

S Vrati1, P J Kerr, R C Weir, L Dalgarno.   

Abstract

Previously we identified the locations of three neutralization epitopes (a, b1 and b2) of Ross River virus (RRV) by sequencing a number of variants resistant to monoclonal antibody neutralization which were found to have single amino acid substitutions in the E2 protein (S. Vrati, C.A. Fernon, L. Dalgarno, and R.C. Weir, Virology 162:346-353, 1988). We have now studied the biological properties of these variants in BHK cells and their virulence in mice. While variants altered in epitopes a and/or b1 showed no difference, variants altered in epitope b2, including a triple variant altered in epitopes a, b1, and b2, showed rapid penetration but retarded kinetics of growth and RNA and protein synthesis in BHK cells compared with RRV T48, the parent virus. Variants altered in epitopes a and/or b1 showed no change in mouse virulence. However, two of the six epitope b2 variants examined had attenuated mouse virulence. They had a four- to fivefold-higher 50% lethal dose (LD50), although no change in the average survival time of infected mice was observed. These variants grew to titers in mouse tissues similar to those of RRV T48. The ID50 of the triple variant was unchanged, but infected mice had an increased average survival time. This variant produced lower levels of viremia in infected mice. On the basis of these findings we propose that both the receptor binding site and neutralization epitopes of RRV are nearby or in the same domain of the E2 protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627696      PMCID: PMC189999     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein.

Authors:  I Seif; P Coulon; P E Rollin; A Flamand
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

2.  Structure of a human common cold virus and functional relationship to other picornaviruses.

Authors:  M G Rossmann; E Arnold; J W Erickson; E A Frankenberger; J P Griffith; H J Hecht; J E Johnson; G Kamer; M Luo; A G Mosser
Journal:  Nature       Date:  1985 Sep 12-18       Impact factor: 49.962

3.  Hemagglutinin-neuraminidase glycoprotein as a determinant of pathogenicity in mumps virus hamster encephalitis: analysis of mutants selected with monoclonal antibodies.

Authors:  A Löve; R Rydbeck; K Kristensson; C Orvell; E Norrby
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

4.  A single nucleotide change in the E2 glycoprotein gene of Sindbis virus affects penetration rate in cell culture and virulence in neonatal mice.

Authors:  N L Davis; F J Fuller; W G Dougherty; R A Olmsted; R E Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

5.  Ross River virus 26 s RNA: complete nucleotide sequence and deduced sequence of the encoded structural proteins.

Authors:  L Dalgarno; C M Rice; J H Strauss
Journal:  Virology       Date:  1983-08       Impact factor: 3.616

6.  Ross River virus mutant with a deletion in the E2 gene: properties of the virion, virus-specific macromolecule synthesis, and attenuation of virulence for mice.

Authors:  S Vrati; S G Faragher; R C Weir; L Dalgarno
Journal:  Virology       Date:  1986-06       Impact factor: 3.616

7.  Ross River virus genetic variants in Australia and the Pacific Islands.

Authors:  S G Faragher; I D Marshall; L Dalgarno
Journal:  Aust J Exp Biol Med Sci       Date:  1985-08

8.  Identification of attenuating mutations on the reovirus type 3 S1 double-stranded RNA segment with a rapid sequencing technique.

Authors:  R Bassel-Duby; D R Spriggs; K L Tyler; B N Fields
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

9.  Characterization of Sindbis virus epitopes important for penetration in cell culture and pathogenesis in animals.

Authors:  R A Olmsted; W J Meyer; R E Johnston
Journal:  Virology       Date:  1986-01-30       Impact factor: 3.616

10.  Epitopes on foot-and-mouth disease virus outer capsid protein VP1 involved in neutralization and cell attachment.

Authors:  B Baxt; D O Morgan; B H Robertson; C A Timpone
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

View more
  5 in total

1.  An amino acid substitution in the coding region of the E2 glycoprotein adapts Ross River virus to utilize heparan sulfate as an attachment moiety.

Authors:  M L Heil; A Albee; J H Strauss; R J Kuhn
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Suppressors of cleavage-site mutations in the p62 envelope protein of Semliki Forest virus reveal dynamics in spike structure and function.

Authors:  I Tubulekas; P Liljeström
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

3.  Identification and characterization of a ross river virus variant that grows persistently in macrophages, shows altered disease kinetics in a mouse model, and exhibits resistance to type I interferon.

Authors:  Brett A Lidbury; Nestor E Rulli; Cristina M Musso; Susan B Cossetto; Ali Zaid; Andreas Suhrbier; Harald S Rothenfluh; Michael S Rolph; Suresh Mahalingam
Journal:  J Virol       Date:  2011-03-23       Impact factor: 5.103

4.  A single mutation in the E2 glycoprotein important for neurovirulence influences binding of sindbis virus to neuroblastoma cells.

Authors:  Peiyu Lee; Ronald Knight; Jolanda M Smit; Jan Wilschut; Diane E Griffin
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

5.  Mutation of neutralizing/antibody-dependent enhancing epitope on spike protein and 7b gene of feline infectious peritonitis virus: influences of viral replication in monocytes/macrophages and virulence in cats.

Authors:  Tomomi Takano; Yoshika Tomiyama; Yasuichiroh Katoh; Michiyo Nakamura; Ryoichi Satoh; Tsutomu Hohdatsu
Journal:  Virus Res       Date:  2011-01-04       Impact factor: 3.303

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.